plushcare semaglutide reviews Review 2026 - Is It Worth It? PlushCare GLP-1 Weight Loss Review

For Mounjaro, across the SURPASS trials in type 2 diabetes, cholelithiasis was reported in 0.6% of tirzepatide-treated patients compared to 0% in the placebo group

Internet: (accessed 26 January 2026) Gillett G, Shivakumar N, James A, and Salmon J

MOTS-c preferentially reduces visceral adipose tissue in the research literature, which is why InBody-tracked patients at Perfect B often see visceral fat changes before overall weight changes

2.4 Multiple sclerosis (MS) Gut dysbiosis is seen in MS patients as marked by decreased microbial diversity and shifts among specific taxa, like increased Akkermansia and reduced SCFA-producers (Jangi et al., 2016)

[DOI] [PMC free article] [PubMed] [Google Scholar] 250

Statistical analysis All data were expressed as mean SD and analyzed using R software (version 4.2)